Milton C. Ault III - 14 Sep 2021 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)

Role: 10%+ Owner
Signature: /s/ Milton C. Ault, III
Issuer symbol: ALZN
Transactions as of: 14 Sep 2021
Net transactions value: +$35,404
Form type: 4
Filing time: 16 Sep 2021, 18:30:10 UTC
Previous filing: 09 Sep 2021
Next filing: 30 Sep 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALZN	Common Stock	Purchase	$13,492	+5,000	+0.07%	$2.70^*	6,720,388	14 Sep 2021	By Digital Power Lending, LLC	F1
holding	ALZN	Common Stock						150,000	14 Sep 2021	Direct
holding	ALZN	Common Stock						15,000,000	14 Sep 2021	By Ault Life Sciences, Inc.	F2
holding	ALZN	Common Stock						10,000,000	14 Sep 2021	By Ault Life Sciences Fund, LLC	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ALZN	Call Option (right to buy)	Purchase	$16,810	+180	+150%	$93.39	300	16 Sep 2021	Common Stock	18,000	$2.50	By Digital Power Lending, LLC	F1, F4, F5
transaction	ALZN	Call Option (right to buy)	Purchase	$5,102	+200	+100%	$25.51^*	400	16 Sep 2021	Common Stock	20,000	$10.00	By Digital Power Lending, LLC	F1, F4
holding	ALZN	Call Option (right to buy)						500	14 Sep 2021	Common Stock	50,000	$5.00	By Digital Power Lending, LLC	F1, F4
holding	ALZN	Call Option (right to buy)						50	14 Sep 2021	Common Stock	5,000	$7.50	By Digital Power Lending, LLC	F1, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Digital Power Lending, LLC ("DPL") is a wholly-owned subsidiary of Ault Global Holdings, Inc. ("AGH"). Mr. Ault, the Executive Chairman of AGH, is deemed to have voting and investment power with respect to the securities held of record by DPL.
F2	Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.
F3	Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.
F4	The security listed is an exchange-traded option contract. Exchange-traded options are immediately exercisable and remain exercisable until expiration.
F5	The options were purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $93.3891. The range of purchase prices on the transaction date was $91.511 to $96.511. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of options purchased at each price.